TITLE

CIMA/aaiPharma Tie the Pharmaceutical Knot

PUB. DATE
August 2003
SOURCE
High Yield Report;8/11/2003, Vol. 14 Issue 32, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports on the proposed merger between U.S.-based pharmaceutical companies aaiPharma and CIMA. Impact of the proposed merger on the financial conditions of the drug manufacturing industry; Estimated capital of the merged companies; Financial standings of the two pharmaceutical companies.
ACCESSION #
10534436

 

Related Articles

  • Pharma says acquisition is the right prescription. Speizer, Irwin // Business North Carolina;Oct2003, Vol. 23 Issue 10, p22 

    Reports on the merger of drug company aaiPharma Inc. with Cima Labs Inc. in 2003. Basis of the consolidation; Impact of the merger on the companies' stock performance; Changes after the merger.

  • aaiPharma to acquire rival Cima Labs.  // PharmaWatch: CNS;September 2003, Vol. 2 Issue 9, p19 

    Reports on the intention of aaiPharma Inc. to acquire Cima Labs Inc. Terms under the deal; Benefits of the agreement for both companies; Significance of the deal for the pharmaceutical biotechnology industry.

  • Hardball Over a Breakup Fee. Sikora, Martin // Mergers & Acquisitions: The Dealermaker's Journal;Sep2004, Vol. 39 Issue 9, p3 

    Reflects on the lawsuit filed by CIMA Labs Inc. against aaiPharma Inc. for fraud and breach of contract. Demands of CIMA; Issues behind the lawsuit filed by CIMA; Effect of breakup fee on the bidding process.

  • Cima Leaves aaiPharma for Cephalon.  // Chemical Market Reporter;11/10/2003, Vol. 264 Issue 16, p2 

    Reports on the ownership and control of the drug delivery technology platform, Cima Labs Inc. won by drug company, Cephalon Inc. over aaiPharma Inc. Terms and details of the stock purchase; Operations and financial performance of the companies; Stock price.

  • Cephalon Maintains CIMA Takeout Will Fly. Cohen, Judy Radler // Mergers & Acquisitions Report;4/12/2004, Vol. 17 Issue 15, p1 

    Discusses the status of the acquisition deal between Cephalon Inc. and CIMA Laboratories Inc. Amount of money involved in the deal; Tender offer of Cephalon Inc. for the shares of CIMA; Information on the two fentanyl products from CIMA Laboratories Inc. that Cephalon Inc. wants to acquire;...

  • Cephalon to acquire Cima Labs for $515 million.  // PharmaWatch: Biotechnology;December 2003, Vol. 2 Issue 12, p22 

    Reports on the plan of Cephalon Inc. to acquire Cima Labs Inc. in the U.S. Value of deal; Terms under the planned acquisition; Benefits of the acquisition for both companies.

  • SDC Worldwide Mergers & Acquisitions.  // Mergers & Acquisitions Report;9/8/2003, Vol. 16 Issue 34, p6 

    Provides an update on several merger and acquisition deals of companies worldwide as of September 8, 2003. CIMA Labs Inc. and Cephalon Inc.; JNI Corp. and Applied Micro Circuits Corp.; Jacksonville Bancorp and Franklin Bank Corp.

  • BEHIND THE NUMBERS. Gebhart, Fred // Drug Topics;4/2/2001, Vol. 145 Issue 7, p48 

    Stresses the effect of the mergers in the United States pharmaceutical industry in 2000. Highlights on the major merger deals; Value of the merger deals; List of drugs that have emerged in the market in 2000; Overview of the drug market in the country.

  • Managing mergers and acquisitions: Lessons from the consolidation of the medical device and diagnostic industry. Caster, Glenn // International Journal of Medical Marketing;Feb2001, Vol. 1 Issue 3, p275 

    Evaluates the report 'Managing Mergers and Acquisitions: Lessons from the Consolidation of the Medical Device and Diagnostic Industry,' by Brian D. Smith. Factors influencing consolidation in the medical industry; Limitation of the report.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics